PT938501E - Processo para a purificacao de um antagonista do receptor de interleucina-1 humana, a partir de e. coli recombinante - Google Patents

Processo para a purificacao de um antagonista do receptor de interleucina-1 humana, a partir de e. coli recombinante

Info

Publication number
PT938501E
PT938501E PT97923960T PT97923960T PT938501E PT 938501 E PT938501 E PT 938501E PT 97923960 T PT97923960 T PT 97923960T PT 97923960 T PT97923960 T PT 97923960T PT 938501 E PT938501 E PT 938501E
Authority
PT
Portugal
Prior art keywords
coli
recombinant
value
receptor antagonist
human interleukin
Prior art date
Application number
PT97923960T
Other languages
English (en)
Inventor
Dino Zanette
Edoardo Giacomo Sarubbi
Adolfo Soffientini
Original Assignee
Aventis Bulk S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Bulk S P A filed Critical Aventis Bulk S P A
Publication of PT938501E publication Critical patent/PT938501E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT97923960T 1996-06-07 1997-05-21 Processo para a purificacao de um antagonista do receptor de interleucina-1 humana, a partir de e. coli recombinante PT938501E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96109153 1996-06-07
PCT/EP1997/002591 WO1997047650A1 (en) 1996-06-07 1997-05-21 Process for the purification of human interleukin-1 receptor antagonist from recombinant e. coli

Publications (1)

Publication Number Publication Date
PT938501E true PT938501E (pt) 2004-11-30

Family

ID=8222862

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97923960T PT938501E (pt) 1996-06-07 1997-05-21 Processo para a purificacao de um antagonista do receptor de interleucina-1 humana, a partir de e. coli recombinante

Country Status (11)

Country Link
EP (1) EP0938501B1 (pt)
JP (1) JP2000512143A (pt)
AT (1) ATE272072T1 (pt)
AU (1) AU717003B2 (pt)
CA (1) CA2257294C (pt)
DE (1) DE69730041T2 (pt)
DK (1) DK0938501T3 (pt)
ES (1) ES2221688T3 (pt)
IL (1) IL127155A (pt)
PT (1) PT938501E (pt)
WO (1) WO1997047650A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9927801D0 (en) * 1999-11-24 2000-01-26 Danisco Method
WO2001041792A1 (en) * 1999-12-10 2001-06-14 Amgen, Inc. Interleukin-1 receptor antagonist-like molecules and uses thereof
US20080166762A1 (en) * 2006-09-27 2008-07-10 Reliance Life Science Pvt.Ltd. HETEROLOGOUS PRODUCTION OF INTERLEUKIN 1 RECEPTOR ANTAGONIST (IL-1Ra) IN PICHIA PASTORIS
AU2008207207B2 (en) 2007-01-15 2012-10-18 Upfront Chromatography A/S Production of biofuel and protein from a raw material
DE202007002869U1 (de) 2007-02-27 2008-07-10 Ds Dichtungstechnik Gmbh Dichtring und Steckmuffenverbindung
SG10201606218WA (en) * 2011-07-29 2016-09-29 Eleven Biotherapeutics Inc Purified Proteins
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
AU2019332100A1 (en) 2018-08-29 2021-03-18 Merck Biodevelopment S.A.S. New purification method

Also Published As

Publication number Publication date
DE69730041T2 (de) 2005-07-21
ES2221688T3 (es) 2005-01-01
IL127155A0 (en) 1999-09-22
CA2257294C (en) 2006-03-14
CA2257294A1 (en) 1997-12-18
EP0938501B1 (en) 2004-07-28
IL127155A (en) 2007-05-15
JP2000512143A (ja) 2000-09-19
EP0938501A1 (en) 1999-09-01
ATE272072T1 (de) 2004-08-15
WO1997047650A1 (en) 1997-12-18
DK0938501T3 (da) 2004-11-15
DE69730041D1 (de) 2004-09-02
AU2958697A (en) 1998-01-07
AU717003B2 (en) 2000-03-16

Similar Documents

Publication Publication Date Title
Kerlavage et al. Covalent modification of an adenosine 3': 5'-monophosphate binding site of the regulatory subunit of cAMP-dependent protein kinase II with 8-azidoadenosine 3': 5'-monophosphate. Identification of a single modified tyrosine residue.
US6471500B1 (en) Process for producing erythropoietin containing no animal proteins
GR3035651T3 (en) Process of high purity albumin production
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
AU698334B2 (en) Method for isolation of highly pure von willebrand factor
AU7575487A (en) Method for the preparation of proteins with factor VIII activity by microbial host cells; expression, vectors, host cells, antibodies
WO1996021007A3 (en) Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells
AU2671795A (en) Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments
ATE73856T1 (de) Reinigung, herstellung und verwendung von tumor- nekrosisfaktoren.
EA199900980A1 (ru) Улучшенные способы приготовления активированного белка с
CA2388716A1 (en) Process for the purification of pharmacologically active proteins through cationic exchange chromatography
AU656552B2 (en) Process for isolating human albumin from supernatant IV, in particular IV-4, or from COHN's fraction V or from an analogous supernatant or fraction
CA2127362A1 (en) Expression and Purification of Recombinant Soluble Tissue Factor
WO1995009872B1 (en) Dna encoding prostaglandin receptor ip
PT938501E (pt) Processo para a purificacao de um antagonista do receptor de interleucina-1 humana, a partir de e. coli recombinante
AU9574198A (en) Method of affinity cross-linking biologically active, immunogenic peptides to antibodies
CA2209858A1 (en) Il-2r-associated polypeptide and dna molecules coding therefor
IE801589L (en) Homogenous fibroblast interferon
WO1995000552B1 (en) Prostaglandin receptor ep3 and dna encoding it
KR900009989A (ko) 내피세포 생장 인자
Lebherz Ontogeny and regulation of fructose diphosphate aldolase isoenzymes in" red" and" white" skeletal muscles of the chick.
CA2010256A1 (en) Protein anti-cancer agent
DE69433902D1 (de) Neuartige tyrosinkinase
EP0811685A3 (en) Human platelet-derived growth factor receptors
PT840746E (pt) Metodo para purificacao de proteinas